Overview

A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic Osteoarthritis (OA) Pain

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of OROS Hydromorphone in reducing moderate to severe chronic pain in patients with Osteoarthritis (OA) Pain
Phase:
Phase 3
Details
Lead Sponsor:
Mallinckrodt
Treatments:
Hydromorphone